Cargando…
Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment
Benefiting from the development of nanotechnology, drug delivery systems (DDSs) with stimuli-responsive controlled release function show great potential in clinical anti-tumor applications. By using a DDS, the harsh side effects of traditional anti-cancer drug treatments and damage to normal tissues...
Autores principales: | Ding, Chendi, Tong, Ling, Feng, Jing, Fu, Jiajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273707/ https://www.ncbi.nlm.nih.gov/pubmed/27999414 http://dx.doi.org/10.3390/molecules21121715 |
Ejemplares similares
-
Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform
por: Cui, Fengzhi, et al.
Publicado: (2022) -
Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery
por: Alsehli, Mosa
Publicado: (2020) -
Recent Progress and Advances of Multi-Stimuli-Responsive Dendrimers in Drug Delivery for Cancer Treatment
por: Le, Ngoc Thuy Trang, et al.
Publicado: (2019) -
Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting
por: Rahim, Muhammad Abdur, et al.
Publicado: (2021) -
Recent Advances in Stimuli-Responsive Metallogels
por: Liu, Zhixiong, et al.
Publicado: (2023)